Treatment of recurrent genotype 4 Hepatitis C after liver transplantation: Early virological response is predictive of sustained virological response. An AISF RECOLT-C group study

Romana Ponziani Francesca, Alessandro Milani, Antonio Gasbarrini, Raffaella Zaccaria, Raffaella Viganò, Maria Francesca Donato, Maria Cristina Morelli, Lucia Miglioresi, Luisa Pasulo, Maria Rendina, Daniele di Paolo, Maria Marino, Pierluigi Toniutto, Stefano Fagiuoli, Maurizio Pompili

Research output: Contribution to journalArticle

Abstract

Introduction. Hepatitis C virus genotype 4 is predominant in the Middle East and Northern Africa, even if it has recently spread to Southern Europe. Data about the treatment of post-liver transplantation (LT) genotype 4 hepatitis C recurrence are scarce. We report a retrospective analysis of post-LT genotype 4 hepatitis C treatment in 9 Italian transplant centres, focusing on the overall survival rates and treatment outcome. Results. Among 452 recipients, we identified 17 HCV genotype 4 patients (16 males, 1 female) transplanted between 1998 and 2007. All patients received combined antiviral treatment with conventional doses of interferon (recombinant or pegylated) and ribavirin after histological diagnosis of hepatitis C recurrence. The observed overall survival after LT was 100% at 1 year and 83.3% at 5 years. More than 1/3 (35.3%) of patients achieved a sustained virological response (SVR) and 40% (data available in 15 subjects) an early virological response (EVR), which was significantly associated with the achievement of SVR (overall accuracy: 85.7%; predictive values of EVR absence/presence 80/88.8%; chi-square p <0.05). Conclusion. In conclusion, in post-LT genotype 4 hepatitis C treatment, SVR rates are similar to genotype 1. Patients who don't show an EVR are not likely to achieve a SVR.

Original languageEnglish
Pages (from-to)338-342
Number of pages5
JournalAnnals of Hepatology
Volume11
Issue number3
Publication statusPublished - 2012

Keywords

  • EVR
  • Genotype 4
  • HCV recurrence
  • HCV treatment
  • Liver transplantation

ASJC Scopus subject areas

  • Hepatology

Fingerprint Dive into the research topics of 'Treatment of recurrent genotype 4 Hepatitis C after liver transplantation: Early virological response is predictive of sustained virological response. An AISF RECOLT-C group study'. Together they form a unique fingerprint.

  • Cite this

    Francesca, R. P., Milani, A., Gasbarrini, A., Zaccaria, R., Viganò, R., Donato, M. F., Morelli, M. C., Miglioresi, L., Pasulo, L., Rendina, M., di Paolo, D., Marino, M., Toniutto, P., Fagiuoli, S., & Pompili, M. (2012). Treatment of recurrent genotype 4 Hepatitis C after liver transplantation: Early virological response is predictive of sustained virological response. An AISF RECOLT-C group study. Annals of Hepatology, 11(3), 338-342.